Comparative evaluation of Logan and relative-equilibrium graphical methods for parametric imaging of dynamic [ 18F]FDDNP PET determinations

NeuroImage

Volumn 60, Issue 1, 2012, Pages 241-251

  Wong, Koon Pong ^a   Kepe, Vladimir ^a   Dahlbom, Magnus ^a   Satyamurthy, Nagichettiar ^a   Small, Gary W ^a,b,c   Barrio, Jorge R ^a   Huang, Sung Cheng ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Mary S Easton Center for Alzheimer's Disease Research   (United States)

Author keywords

18F FDDNP; Alzheimer's disease (AD); Distribution volume ratio (DVR); Graphical methods; Positron emission tomography (PET)

Indexed keywords

2 [1 [6 [[2 FLUOROETHYL](METHYL)AMINO] 2 NAPHTHYL]ETHYLIDENE]MALONONITRILE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC IMAGING; DISTRIBUTION VOLUME RATIO; DRUG BINDING; FEMALE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; IMAGING AND DISPLAY; INTERMETHOD COMPARISON; LOGAN GRAPHICAL ANALYSIS; MALE; NEUROIMAGING; PLOTS AND CURVES; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY CONCENTRATION RATIO; RADIOLOGICAL PARAMETERS; RELATIVE EQUILIBRIUM GRAPHICAL ANALYSIS; TIME WINDOW; TOTAL SCAN DURATION; VOXEL WISE PARAMETRIC IMAGING;

AGED; ALZHEIMER DISEASE; DATA INTERPRETATION, STATISTICAL; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; NITRILES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84862830552     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.12.014     Document Type: Article

References (46)

1. Agdeppa E.D., Kepe V., Liu J., Flores-Torres S., Satyamurthy N., Petric A., Cole G.M., Small G.W., Huang S.-C., Barrio J.R. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for β-amyloid plaques in Alzheimer's disease. J. Neurosci. 2001, 21(RC189):181-185.
2. Barrio J.R., Huang S.-C., Cole G., Satyamurthy N., Petric A., Phelps M.E., Small G. PET imaging of tangles and plaques in Alzheimer disease with a highly hydrophobic probe. J. Labelled Comp. Radiopharm. 1999, 42:S194-S195.
3. Barrio J.R., Satyamurthy N., Huang S.-C., Petrič A., Small G.W., Kepe V. Dissecting molecular mechanisms in the living brain of dementia patients. Acc. Chem. Res. 2009, 42:842-850.
4. Barrio J.R., Bordelon Y., Small G.W., Kepe V. Visualizing tau pathology in the living brain of progressive supranuclear palsy patients. 10th International Conference on Alzheimer's & Parkinson's Diseases (AD/PD 2011), Barcelona, Spain 2011.
5. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
6. Carson R.E. Precision and accuracy considerations of physiological quantitation in PET. J. Cereb. Blood Flow Metab. 1991, 11:A45-A50.
7. Carson R.E. PET parameter estimation using linear integration methods: bias and variability considerations. Quantification of Brain Function: Tracer Kinetic and Image Analysis in Brain PET 1993, 499-507. Excerpta Medica, New York. K. Uemura, N.A. Lassen, T. Jones, I. Kanno (Eds.).
8. Draper N.R., Smith H. Applied Regression Analysis 1981, John Wiley & Sons, New York. 2nd ed.
9. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J. Psychiat. Res. 1975, 12:189-198.
10. Golub G.H., Van Loan C.F. Matrix Computations 1996, The Johns Hopkins University Press, Baltimore. 3rd ed.
11. Huang S.-C., Phelps M.E. Principles of tracer kinetic modeling in positron emission tomography and autoradiography. Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart 1986, 287-346. Raven Press, New York. M.E. Phelps, J.C. Mazziotta, H.R. Schelbert (Eds.).
12. Huang S.-C., Barrio J.R., Phelps M.E. Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches. J. Cereb. Blood Flow Metab. 1986, 6:515-521.
13. Ichise M., Toyama H., Innis R.B., Carson R.E. Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J. Cereb. Blood Flow Metab. 2002, 22:1271-1281.
14. 11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J. Cereb. Blood Flow Metab. 2003, 23:1096-1112.
15. Joachim C.L., Morris J.H., Selkoe D.J. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. Am. J. Pathol. 1989, 135:309-319.
16. Kepe V., Ghetti B., Farlow M., Bresjanac M., Miller K., Huang S.-C., Wong K.-P., Murrell J.R., Piccardo P., Epperson F., Reposvš G., Smid L.M., Petrič A., Siddarth P., Liu J., Satyamurthy N., Small G.W., Barrio J.R. PET of brain prion protein amyloid in Gerstmann-Sträussler-Scheinker disease. Brain Pathol. 2010, 20:419-430.
17. Lammertsma A.A., Hume S.P. Simplified reference tissue model for PET receptor studies. NeuroImage 1996, 4:153-158.
18. 11C]raclopride studies. J. Cereb. Blood Flow Metab. 1996, 16:42-52.
19. Landau M., Sawaya M.R., Faull K.F., Laganowsky A., Jiang L., Sievers S.A., Liu J., Barrio J.R., Eisenberg D. Towards a pharmacophore for amyloid. PLoS Biol. 2011, 9(6):e1001080.
20. 18F]FDDNP) ready for animal or human administration. Mol. Imaging Biol. 2007, 9:6-16.
21. Logan J. A review of graphical methods for tracer studies and strategies to reduce bias. Nucl. Med. Biol. 2003, 30:833-844.
22. 11C-methyl]-(-)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab. 1990, 10:740-747.
23. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 1996, 16:834-840.
24. Logan J., Fowler J.S., Volkow N.D., Ding Y.S., Wang G.-J., Alexoff D.L. A strategy for removing the bias in the graphical analysis method. J. Cereb. Blood Flow Metab. 2001, 21:307-320.
25. Logan J., Alexoff D., Fowler J.S. The use of alternative forms of graphical analysis to balance bias and precision in PET images. J. Cereb. Blood Flow Metab. 2011, 31:535-546.
26. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
27. Ogden R.T. Estimation of kinetic parameters in graphical analysis of PET imaging data. Stat. Med. 2003, 22:3557-3568.
28. Patlak C.S., Blasberg R.G. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J. Cereb. Blood Flow Metab. 1985, 5:584-590.
29. Patlak C.S., Blasberg R.G., Fenstermacher J. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 1983, 3:1-7.
30. Protas H.D., Huang S.-C., Kepe V., Hayashi K., Klunder A., Braskie M.N., Ercoli L., Bookheimer S., Thompson P.M., Small G.W., Barrio J.R. FDDNP binding using MR derived cortical surface maps. NeuroImage 2010, 49:240-248.
31. Seber G.A.F., Wild C.J. Nonlinear Regression 1989, John Wiley & Sons, New York.
32. Shin J., Lee S.-Y., Kim S.-H., Kim Y.-B., Cho S.-J. Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease. NeuroImage 2008, 43:236-244.
33. Slifstein M., Laruelle M. Effects of statistical noise on graphic analysis of PET neuroreceptor studies. J. Nucl. Med. 2000, 41:2083-2088.
34. Small G.W., Kepe V., Ercoli L.M., Siddarth P., Bookheimer S.Y., Miller K.J., Lavretsky H., Burggren A.C., Cole G.M., Vinters H.V., Thompson P.M., Huang S.C., Satyamurthy N., Phelps M.E., Barrio J.R. PET of brain amyloid and tau in mild cognitive impairment. N. Engl. J. Med. 2006, 355:2652-2663.
35. Smid L.M., Vovko T.D., Popovic M., Petrič A., Kepe V., Barrio J.R., Vidmar G., Bresjanac M. The 2,6-disubstituted naphthalence derivative FDDNP labeling reliably predicts congo red birefringence of protein deposits in brain sections of selected human neurodegenerative diseases. Brain Pathol. 2006, 16:124-130.
36. Teng E., Kepe V., Frautschy S.A., Liu J., Satyamurthy N., Yang F., Chen P.-P., Cole G.B., Jones M.R., Huang S.-C., Flood D.G., Trusko S.P., Small G.W., Cole G.M., Barrio J.R. [F-18]FDDNP microPET imaging correlates with brain Aβ burden in a transgenic rat model of Alzheimer disease: effects of aging, in vivo blockade, and anti-Aβ antibody treatment. Neurobiol. Dis. 2011, 43:565-575.
37. Varga J., Szabo Z. Modified regression model for the Logan plot. J. Cereb. Blood Flow Metab. 2002, 22:240-244.
38. 18F-FDDNP scans. J. Nucl. Med. 2010, 51:510-518.
39. 18F]FDDNP PET data. IEEE Nuclear Science Symposium and Medical Imaging Conference Record, Honolulu, Hawaii 2007, 3146-3150.
40. 18F]FDDNP PET studies for brain amyloid imaging. IEEE Nuclear Science Symposium and Medical Imaging Conference Record, Honolulu, Hawaii 2007, 3974-3977.
41. 18F]FDDNP PET using subcortical white matter as reference region. Eur. J. Nucl. Med. Mol. Imaging 2010, 37:575-588.
42. 18F]FDDNP studies. Mol. Imaging Biol. 2009, 11:322-333.
43. 18F]FDDNP studies. NeuroImage 2010, 49:433-441.
44. Zar J.H. Biostatistical Analysis 1999, Prentice-Hall, Upper Saddle River, NJ. 4th ed.
45. Zhou Y., Ye W., Brašić J.R., Crabb A.H., Hilton J., Wong D.F. A consistent and efficient graphical analysis method to improve the quantification of reversible tracer binding in radioligand receptor dynamic PET studies. NeuroImage 2009, 44:661-670.
46. Zhou Y., Ye W., Brašić J.R., Wong D.F. Multi-graphical analysis of dynamic PET. NeuroImage 2010, 49:2947-2957.